The Retinal Disease Therapeutics Market was valued at US$ 20.63 Billion in 2025 and is projected to reach US$ 42.91 Billion by 2033, growing at a CAGR of 9.59% during 2026–2033. The retrieved public source material for this batch did not expose all three headline values required for a verified numerical opening, so no market-size figure or CAGR is inferred. Management should view the...